Company: CERO
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112619
Chunk: 341

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 2
Chunk 341
---
.
  
    **
    Furnished
    herewith.
  
    †
    Certain
    portions of this document that constitute confidential information have been redacted pursuant to Item 601(b)(10) of Regulation S-K.

53

SIGNATURES

In accordance with the requirements of the Exchange
Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    CERO THERAPEUTICS
    HOLDINGS, INC.

    Date: November 19, 2025
    By:
    /s/
    Chris Ehrlich

    Name: 
    Chris Ehrlich

    Title:
    Chairman and Chief Executive
    Officer

    (Principal Executive Officer)

    Date: November 19, 2025
    By:
    /s/
    Andrew Kucharchuk

    Name:
    Andrew Kucharchuk

    Title:
    Chief Financial Officer

    (Principal Financial and
    Accounting Officer)

54

NONE
NONE

http://fasb.org/srt/2025#ChiefExecutiveOfficerMember

0001870404
false
Q3
--12-31

    0001870404

    2025-01-01
    2025-09-30

    0001870404
    
      cero:CommonStockParValue00001PerShareMember

    2025-01-01
    2025-09-30

    0001870404
    
      cero:WarrantsEachWarrantExercisableForOneTwoThousandthsOfAShareOfCommonStockMember

    2025-01-01
    2025-09-30

    0001870404

    2025-11-19

    0001870404

    2025-09-30

    0001870404

    2024-12-31

    0001870404
    
      cero:SeriesCConvertiblePreferredStockMember

    2025-09-30

    0001870404
    
      cero:SeriesCConvertiblePreferredStockMember

    2024-12-31

    0001870404
    
      cero:SeriesDConvertiblePreferredStockMember

    2025-09-30

    0001870404
    
      cero:SeriesDConvertiblePreferredStockMember

    2024-12